Can AI chatbots replace doctor questionnaires for chronic pain patients?

NCT ID NCT07336537

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether conversational AI software can effectively collect health information from people with chronic pain. Participants will chat with a digital tool that asks about their physical symptoms, emotions, and social life. The goal is to see if patients find this approach acceptable, easy to use, and practical for real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Digital Biopsychosocial Conversational Data Collection Software (AI-powered chatbot)

What this could lead to

If successful, this could show that conversational AI is a practical way to gather detailed health information from chronic pain patients, potentially improving how their condition is understood and managed.

What could go wrong

This is a small, early-stage feasibility study (100 participants) with no control group. It only measures how acceptable and usable the software is, not whether it improves health outcomes. Technical glitches or patient discomfort with AI conversations could limit its usefulness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome mental disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • AugMend Health at MIT.nano Immersion Lab

    RECRUITING

    Cambridge, Massachusetts, 02139, United States

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••